← Back to Search

Control Group - for Chronic Kidney Disease (PACE-CKD Trial)

N/A

Recruiting

Led By Andrea Oliverio, MD, MSc

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any Chronic Kidney Disease (CKD) diagnosis

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PACE-CKD Trial Summary

This trial is a small study that aims to test a tool that helps patients with chronic kidney disease make decisions about pregnancy and contraception. The study will also look at how well the tool works and if patients

Who is the study for?

This trial is for patients with chronic kidney disease who are interested in making informed decisions about their reproductive health. Specific eligibility criteria have not been provided, but typically such trials require participants to be adults capable of consent and without conditions that might interfere with the study.Check my eligibility

What is being tested?

The study is testing a special decision aid designed to help kidney disease patients understand their options regarding pregnancy and contraception. This will be compared to standard informational handouts. The goal is to see if the decision aid improves understanding and decision-making.See study design

What are the potential side effects?

Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating in this study.

PACE-CKD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with chronic kidney disease.

PACE-CKD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Preparation for Decision Making (PrepDM) score at post-intervention

Secondary outcome measures

Acceptability of delivering a reproductive health decision aid in a nephrology clinic -participants

Acceptability of delivering a reproductive health decision aid in a nephrology clinic- nephrologists

Feasibility of delivering a reproductive health decision aid in a nephrology clinic - nephrologists

+2 more

PACE-CKD Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention Group - Decision aidExperimental Treatment1 Intervention

Group II: Control Group -Experimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Decision aid

2018

N/A

~17570

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,522 Total Patients Enrolled

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,378,068 Total Patients Enrolled

Andrea Oliverio, MD, MScPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to participate in this research trial?

"In order to be considered for enrollment in this medical study, individuals must have a diagnosis of chronic kidney disease and fall within the age range of 18 to 45 years. The trial is currently seeking a total of 70 eligible participants."

Answered by AI

Are potential participants still able to apply for enrollment in this ongoing research study?

"As per clinicaltrials.gov, this specific trial is not currently seeking participants. The initial posting of the study was on January 1st, 2024, and it was last updated on December 18th, 2023. However, there are presently an impressive number of 502 other active clinical trials that are actively accepting candidates for participation."

Answered by AI

Is there an age restriction for individuals participating in this clinical trial, specifically excluding those above 85 years of age?

"To be eligible for this research study, potential participants must fall between the ages of 18 and 45. It is worth noting that there are a total of 41 trials specifically targeting patients under 18 years old, as well as an additional 461 trials focusing on individuals over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

Andrea Oliverio 2024. "Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06189807.

All > Chronic Kidney Disease